{
    "hands_on_practices": [
        {
            "introduction": "Polyene antifungals like amphotericin B exert their effect by directly binding to ergosterol in the fungal membrane, assembling into pores that cause lethal ion leakage. This exercise guides you through the biophysical principles governing this process, from the initial drug-target binding to the resulting electrical current across the membrane. By applying the law of mass action, you will connect the drug's dissociation constant ($K_D$) and concentration to the measurable damage it inflicts, providing a quantitative look at this powerful mechanism of action .",
            "id": "4648555",
            "problem": "A patch of fungal plasma membrane contains ergosterol-rich sites to which amphotericin B binds and, upon binding, can assemble transmembrane pores that increase ionic leakage. Consider the reversible binding reaction between free drug and unoccupied ergosterol sites,\n$$\nD + R \\rightleftharpoons DR,\n$$\nwhere $D$ denotes amphotericin B in the membrane phase, $R$ denotes an unoccupied ergosterol site, and $DR$ denotes the drug-bound site. The dissociation constant (denoted as $K_{D}$) is defined by the Law of Mass Action as\n$$\nK_{D} \\equiv \\frac{[D][R]}{[DR]} = \\frac{k_{\\mathrm{off}}}{k_{\\mathrm{on}}},\n$$\nwith $k_{\\mathrm{on}}$ and $k_{\\mathrm{off}}$ the association and dissociation rate constants, respectively. Starting from this definition and the conservation relation $[R]_{\\mathrm{tot}} = [R] + [DR]$, derive the fractional occupancy $ \\theta \\equiv \\frac{[DR]}{[R]_{\\mathrm{tot}}}$ as a function of $[D]$ and $K_{D}$, and then evaluate $\\theta$ for the membrane drug concentration $[D] = 0.5\\,\\mu\\mathrm{M}$ and $K_{D} = 0.1\\,\\mu\\mathrm{M}$.\n\nTo connect occupancy to leakage current, model each amphotericin B pore as an ohmic conductor with single-pore conductance $\\gamma$, so that the current contributed by $n_{\\mathrm{open}}$ simultaneously open pores under transmembrane potential $V$ is $I_{\\mathrm{pore}} = n_{\\mathrm{open}}\\,\\gamma\\,V$. Assume the patch contains $N_{s}$ ergosterol sites that could host a pore when drug is bound, and that for a drug-bound site, the probability of successfully assembling a conducting pore that is open under the given conditions is $p$. In the absence of drug, the patch exhibits a baseline leak current $I_{\\mathrm{base}}$. Using these assumptions and your derived expression for $\\theta$, compute the expected change in leakage current $\\Delta I \\equiv I_{\\mathrm{total}} - I_{\\mathrm{base}}$ for the parameter values $N_{s} = 120$, $p = 0.6$, $\\gamma = 200\\,\\mathrm{pS}$, $V = 50\\,\\mathrm{mV}$, $I_{\\mathrm{base}} = 30\\,\\mathrm{pA}$, $[D] = 0.5\\,\\mu\\mathrm{M}$, and $K_{D} = 0.1\\,\\mu\\mathrm{M}$. Round your final numerical answer for $\\Delta I$ to three significant figures and express it in $\\mathrm{nA}$.",
            "solution": "The user has asked for a solution to a problem. As per the instructions, the first step is to validate the problem statement.\n\n### Step 1: Extract Givens\nThe data, variables, and conditions provided in the problem statement are:\n-   Binding reaction: $D + R \\rightleftharpoons DR$\n-   Definition of dissociation constant: $K_{D} \\equiv \\frac{[D][R]}{[DR]} = \\frac{k_{\\mathrm{off}}}{k_{\\mathrm{on}}}$\n-   Conservation of total sites: $[R]_{\\mathrm{tot}} = [R] + [DR]$\n-   Definition of fractional occupancy: $\\theta \\equiv \\frac{[DR]}{[R]_{\\mathrm{tot}}}$\n-   Membrane drug concentration for evaluation: $[D] = 0.5\\,\\mu\\mathrm{M}$\n-   Dissociation constant for evaluation: $K_{D} = 0.1\\,\\mu\\mathrm{M}$\n-   Pore current model: $I_{\\mathrm{pore}} = n_{\\mathrm{open}}\\,\\gamma\\,V$\n-   Total number of ergosterol sites: $N_{s} = 120$\n-   Probability of pore formation from a bound site: $p = 0.6$\n-   Single-pore conductance: $\\gamma = 200\\,\\mathrm{pS}$\n-   Transmembrane potential: $V = 50\\,\\mathrm{mV}$\n-   Baseline leak current: $I_{\\mathrm{base}} = 30\\,\\mathrm{pA}$\n-   Definition of change in leakage current: $\\Delta I \\equiv I_{\\mathrm{total}} - I_{\\mathrm{base}}$\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed against the validation criteria:\n-   **Scientifically Grounded**: The problem is well-grounded in biophysical principles. The binding kinetics are described by the Law of Mass Action, leading to a standard Langmuir binding isotherm, a cornerstone model for receptor-ligand interactions. The electrical properties of the pores are modeled using Ohm's law, which is a valid approximation for ion channels under many conditions. The mechanism and parameters described are consistent with the known action of polyene antifungals like amphotericin B. The problem is scientifically sound.\n-   **Well-Posed**: The problem is well-posed. It provides all necessary information and definitions to derive the expression for fractional occupancy and to compute the final numerical value for the change in current. The tasks are clearly specified.\n-   **Objective**: The problem is stated in precise, objective language without subjective or opinion-based elements.\n\nThe problem does not exhibit any flaws such as scientific unsoundness, incompleteness, contradiction, or ambiguity. It is a valid quantitative problem in biophysics.\n\n### Step 3: Verdict and Action\nThe problem is deemed valid. A complete solution will be provided.\n\n### Solution Derivation\nThe problem is divided into two parts: first, deriving the fractional occupancy $\\theta$ and evaluating it; second, using this result to compute the expected change in leakage current $\\Delta I$.\n\n**Part 1: Derivation and Evaluation of Fractional Occupancy $\\theta$**\n\nThe fractional occupancy $\\theta$ is defined as the ratio of the concentration of drug-bound sites, $[DR]$, to the total concentration of available sites, $[R]_{\\mathrm{tot}}$.\n$$\n\\theta \\equiv \\frac{[DR]}{[R]_{\\mathrm{tot}}}\n$$\nThe total concentration of sites is the sum of unoccupied sites, $[R]$, and occupied sites, $[DR]$:\n$$\n[R]_{\\mathrm{tot}} = [R] + [DR]\n$$\nFrom this conservation relation, we can express the concentration of unoccupied sites as:\n$$\n[R] = [R]_{\\mathrm{tot}} - [DR]\n$$\nThe dissociation constant, $K_D$, is defined by the equilibrium condition of the binding reaction:\n$$\nK_{D} = \\frac{[D][R]}{[DR]}\n$$\nSubstituting the expression for $[R]$ into the definition of $K_D$:\n$$\nK_{D} = \\frac{[D]([R]_{\\mathrm{tot}} - [DR])}{[DR]}\n$$\nTo solve for $\\theta$, we rearrange this equation to isolate the term $\\frac{[DR]}{[R]_{\\mathrm{tot}}}$.\n$$\nK_{D}[DR] = [D][R]_{\\mathrm{tot}} - [D][DR]\n$$\n$$\nK_{D}[DR] + [D][DR] = [D][R]_{\\mathrm{tot}}\n$$\n$$\n[DR](K_{D} + [D]) = [D][R]_{\\mathrm{tot}}\n$$\nDividing both sides by $[R]_{\\mathrm{tot}}$ and by $(K_{D} + [D])$ yields the expression for fractional occupancy:\n$$\n\\frac{[DR]}{[R]_{\\mathrm{tot}}} = \\frac{[D]}{[D] + K_{D}}\n$$\nThus,\n$$\n\\theta = \\frac{[D]}{[D] + K_{D}}\n$$\nThis is the required expression for fractional occupancy as a function of $[D]$ and $K_{D}$.\n\nNow, we evaluate $\\theta$ for the given values $[D] = 0.5\\,\\mu\\mathrm{M}$ and $K_{D} = 0.1\\,\\mu\\mathrm{M}$.\n$$\n\\theta = \\frac{0.5\\,\\mu\\mathrm{M}}{0.5\\,\\mu\\mathrm{M} + 0.1\\,\\mu\\mathrm{M}} = \\frac{0.5}{0.6} = \\frac{5}{6}\n$$\n\n**Part 2: Calculation of the Expected Change in Leakage Current $\\Delta I$**\n\nThe total current, $I_{\\mathrm{total}}$, is the sum of the baseline current, $I_{\\mathrm{base}}$, and the current induced by the amphotericin B pores, $I_{\\mathrm{pore}}$.\n$$\nI_{\\mathrm{total}} = I_{\\mathrm{base}} + I_{\\mathrm{pore}}\n$$\nThe change in leakage current, $\\Delta I$, is defined as:\n$$\n\\Delta I = I_{\\mathrm{total}} - I_{\\mathrm{base}} = I_{\\mathrm{pore}}\n$$\nThe current through the pores is given by $I_{\\mathrm{pore}} = n_{\\mathrm{open}}\\,\\gamma\\,V$, where $n_{\\mathrm{open}}$ is the number of open pores. We need to find the *expected* number of open pores, $\\langle n_{\\mathrm{open}} \\rangle$.\n\nThe total number of potential pore sites is $N_s$. The probability of any given site being occupied by a drug molecule is the fractional occupancy, $\\theta$. Thus, the expected number of drug-bound sites is $N_s \\theta$.\nGiven that a site is occupied, the probability of it forming an open, conducting pore is $p$. Therefore, the expected number of open pores is the product of the expected number of bound sites and the probability $p$:\n$$\n\\langle n_{\\mathrm{open}} \\rangle = (N_s \\theta) \\cdot p = N_s p \\theta\n$$\nThe expected change in leakage current is then:\n$$\n\\Delta I = \\langle n_{\\mathrm{open}} \\rangle \\gamma V = N_s p \\theta \\gamma V\n$$\nSubstituting the expression for $\\theta$:\n$$\n\\Delta I = N_s p \\gamma V \\left( \\frac{[D]}{[D] + K_D} \\right)\n$$\nWe can now substitute the given numerical values:\n-   $N_s = 120$\n-   $p = 0.6$\n-   $\\gamma = 200\\,\\mathrm{pS} = 200 \\times 10^{-12}\\,\\mathrm{S}$\n-   $V = 50\\,\\mathrm{mV} = 50 \\times 10^{-3}\\,\\mathrm{V}$\n-   $\\theta = 5/6$ (as calculated previously)\n\nFirst, let's calculate the expected number of open pores:\n$$\n\\langle n_{\\mathrm{open}} \\rangle = N_s p \\theta = 120 \\times 0.6 \\times \\frac{5}{6} = (120/6) \\times 0.6 \\times 5 = 20 \\times 0.6 \\times 5 = 60\n$$\nSo, we expect $60$ pores to be open on average.\n\nNext, we calculate the current through a single open pore, $I_{\\mathrm{single}}$:\n$$\nI_{\\mathrm{single}} = \\gamma V = (200 \\times 10^{-12}\\,\\mathrm{S}) \\times (50 \\times 10^{-3}\\,\\mathrm{V}) = 10000 \\times 10^{-15}\\,\\mathrm{A} = 10 \\times 10^{-12}\\,\\mathrm{A} = 10\\,\\mathrm{pA}\n$$\nThe total expected change in current is the product of the expected number of open pores and the single-pore current:\n$$\n\\Delta I = \\langle n_{\\mathrm{open}} \\rangle \\times I_{\\mathrm{single}} = 60 \\times 10\\,\\mathrm{pA} = 600\\,\\mathrm{pA}\n$$\nThe problem asks for the answer to be expressed in nanoamperes ($\\mathrm{nA}$). Using the conversion $1\\,\\mathrm{nA} = 1000\\,\\mathrm{pA}$:\n$$\n\\Delta I = 600\\,\\mathrm{pA} \\times \\frac{1\\,\\mathrm{nA}}{1000\\,\\mathrm{pA}} = 0.6\\,\\mathrm{nA}\n$$\nFinally, rounding the result to three significant figures gives $0.600\\,\\mathrm{nA}$.",
            "answer": "$$\n\\boxed{0.600}\n$$"
        },
        {
            "introduction": "Many antifungals function by inhibiting essential enzymes. This practice explores the action of terbinafine, which targets squalene epoxidase, a key enzyme in the ergosterol biosynthesis pathway. You will apply the principles of Michaelis-Menten kinetics to calculate how a competitive inhibitor like terbinafine reduces the enzyme's activity, thereby halting the production of a vital membrane component and demonstrating a classic pharmacological mechanism .",
            "id": "4648612",
            "problem": "Terbinafine is an allylamine antifungal that inhibits the fungal squalene epoxidase Erg1 (Ergosterol 1) by binding competitively with the substrate squalene. Consider a fungal cell in steady state where Erg1 is the rate-limiting step for ergosterol synthesis under the given conditions. Assume Michaelisâ€“Menten kinetics for Erg1 with competitive inhibition by terbinafine. The uninhibited enzyme has a Michaelis constant $K_{m}$ for squalene of $2\\,\\mu\\text{M}$, and the intracellular squalene concentration is $[S]=10\\,\\mu\\text{M}$. Terbinafine is present at $[I]=0.2\\,\\mu\\text{M}$, and its inhibition constant is $K_{i}=50\\,\\text{nM}$. Using these values, calculate the fractional inhibition of Erg1 activity due to terbinafine and, under the assumption that Erg1 is rate-limiting, report the same fractional reduction in ergosterol synthesis rate as a single decimal value. Round your final answer to four significant figures and express it with no units.",
            "solution": "The problem statement is evaluated to be valid. It is scientifically grounded in the principles of enzyme kinetics, specifically Michaelis-Menten kinetics with competitive inhibition. It is well-posed, providing all necessary parameters ($K_m$, $[S]$, $[I]$, $K_i$) to calculate a unique, meaningful answer. The language is objective and the values are biochemically plausible.\n\nThe objective is to calculate the fractional inhibition, $f_i$, of the enzyme Erg1 by the competitive inhibitor terbinafine. The fractional inhibition is defined as the fractional decrease in the reaction velocity caused by the inhibitor. It can be expressed as:\n$$\nf_i = \\frac{v_0 - v_i}{v_0} = 1 - \\frac{v_i}{v_0}\n$$\nwhere $v_0$ is the initial velocity of the uninhibited reaction and $v_i$ is the initial velocity in the presence of the inhibitor.\n\nAccording to the Michaelis-Menten model, the velocity of the uninhibited reaction is given by:\n$$\nv_0 = \\frac{V_{\\text{max}}[S]}{K_m + [S]}\n$$\nwhere $V_{\\text{max}}$ is the maximum reaction velocity, $[S]$ is the substrate concentration, and $K_m$ is the Michaelis constant.\n\nFor competitive inhibition, the inhibitor binds reversibly to the enzyme's active site, competing with the substrate. The presence of a competitive inhibitor increases the apparent Michaelis constant ($K_{m, \\text{app}}$) but does not affect $V_{\\text{max}}$. The velocity of the inhibited reaction is:\n$$\nv_i = \\frac{V_{\\text{max}}[S]}{K_{m, \\text{app}} + [S]}\n$$\nwhere the apparent Michaelis constant is given by:\n$$\nK_{m, \\text{app}} = K_m \\left(1 + \\frac{[I]}{K_i}\\right)\n$$\nHere, $[I]$ is the inhibitor concentration and $K_i$ is the inhibition constant.\n\nTo find the fractional inhibition, we first compute the ratio of the inhibited velocity to the uninhibited velocity, $\\frac{v_i}{v_0}$:\n$$\n\\frac{v_i}{v_0} = \\frac{\\frac{V_{\\text{max}}[S]}{K_m \\left(1 + \\frac{[I]}{K_i}\\right) + [S]}}{\\frac{V_{\\text{max}}[S]}{K_m + [S]}}\n$$\nThe term $V_{\\text{max}}[S]$ cancels out, yielding:\n$$\n\\frac{v_i}{v_0} = \\frac{K_m + [S]}{K_m \\left(1 + \\frac{[I]}{K_i}\\right) + [S]}\n$$\n\nThe problem provides the following values:\n- Michaelis constant, $K_m = 2\\,\\mu\\text{M}$\n- Substrate (squalene) concentration, $[S] = 10\\,\\mu\\text{M}$\n- Inhibitor (terbinafine) concentration, $[I] = 0.2\\,\\mu\\text{M}$\n- Inhibition constant, $K_i = 50\\,\\text{nM}$\n\nBefore proceeding with the calculation, we must ensure all concentrations are in consistent units. We will convert $K_i$ from nanomolar ($\\text{nM}$) to micromolar ($\\mu\\text{M}$):\n$$\nK_i = 50\\,\\text{nM} = 50 \\times 10^{-3}\\,\\mu\\text{M} = 0.05\\,\\mu\\text{M}\n$$\nNow we can calculate the term $\\left(1 + \\frac{[I]}{K_i}\\right)$:\n$$\n1 + \\frac{[I]}{K_i} = 1 + \\frac{0.2\\,\\mu\\text{M}}{0.05\\,\\mu\\text{M}} = 1 + 4 = 5\n$$\nThis allows us to calculate the apparent Michaelis constant, $K_{m, \\text{app}}$:\n$$\nK_{m, \\text{app}} = K_m \\left(1 + \\frac{[I]}{K_i}\\right) = (2\\,\\mu\\text{M})(5) = 10\\,\\mu\\text{M}\n$$\nNow, substitute the values into the expression for the velocity ratio $\\frac{v_i}{v_0}$:\n$$\n\\frac{v_i}{v_0} = \\frac{K_m + [S]}{K_{m, \\text{app}} + [S]} = \\frac{2\\,\\mu\\text{M} + 10\\,\\mu\\text{M}}{10\\,\\mu\\text{M} + 10\\,\\mu\\text{M}} = \\frac{12\\,\\mu\\text{M}}{20\\,\\mu\\text{M}} = 0.6\n$$\nThe fractional activity remaining is $0.6$. The fractional inhibition, $f_i$, is therefore:\n$$\nf_i = 1 - \\frac{v_i}{v_0} = 1 - 0.6 = 0.4\n$$\nThe problem states that Erg1 is the rate-limiting step for ergosterol synthesis. Therefore, the fractional reduction in the overall rate of ergosterol synthesis is equal to the fractional inhibition of the Erg1 enzyme. The final answer must be rounded to four significant figures.\n$$\nf_i = 0.4000\n$$",
            "answer": "$$\n\\boxed{0.4000}\n$$"
        },
        {
            "introduction": "A drug's effectiveness depends on its ability to reach and maintain a sufficient concentration inside the target cell. Fungi can develop resistance by actively pumping the drug out, a common mechanism against azoles. This problem challenges you to build a simple pharmacokinetic model for the balance of drug influx and efflux, and to quantify how much the Minimum Inhibitory Concentration (MIC) increases when a fungus overexpresses these efflux pumps .",
            "id": "4648618",
            "problem": "A filamentous fungus is treated with an azole antifungal whose primary target is lanosterol $14\\alpha$-demethylase (also known as cytochrome P450 $51$, abbreviated CYP51). Growth inhibition emerges when the intracellular antifungal concentration exceeds a threshold $C^{\\star}$ at which enzyme activity is sufficiently suppressed. Assume the following transport and elimination processes: drug influx into the cell is first-order in the extracellular drug concentration $[D]$ with rate constant $k_{\\text{in}}$, while drug efflux and intracellular metabolic transformation are each first-order in the intracellular concentration $C_{\\text{in}}$ with rate constants $k_{\\text{out}}$ and $k_{\\text{met}}$, respectively. An ATP-Binding Cassette (ABC) efflux transporter is overexpressed in a resistant mutant, increasing the efflux rate constant by a multiplicative factor $r$ relative to a baseline strain.\n\nStarting from a mass-balance statement for the intracellular drug concentration under these first-order processes, derive the steady-state intracellular concentration $C_{\\text{in}}$ as a function of $[D]$, $k_{\\text{in}}$, $k_{\\text{out}}$, and $k_{\\text{met}}$. Define the Minimum Inhibitory Concentration (MIC) as the extracellular concentration $[D]$ for which $C_{\\text{in}} = C^{\\star}$, and express the MIC in terms of the rate constants and $C^{\\star}$. Then, given the parameters $k_{\\text{in}} = 0.40\\ \\text{min}^{-1}$, $k_{\\text{out},0} = 0.10\\ \\text{min}^{-1}$, $k_{\\text{met}} = 0.02\\ \\text{min}^{-1}$, $C^{\\star} = 1.50\\ \\mu\\text{M}$, and an efflux upregulation factor $r = 3.5$ (so that the resistant strain has $k_{\\text{out}} = r\\,k_{\\text{out},0}$), compute the fold-change in the MIC produced by efflux overexpression, defined as the ratio of the resistant-strain MIC to the baseline-strain MIC. Report the fold-change as a pure number, rounded to four significant figures.",
            "solution": "The problem is first subjected to validation.\n\n### Step 1: Extract Givens\n- Primary target of azole antifungal: lanosterol $14\\alpha$-demethylase (CYP51).\n- Growth inhibition threshold: intracellular concentration $C^{\\star}$.\n- Drug influx: first-order in extracellular drug concentration $[D]$ with rate constant $k_{\\text{in}}$.\n- Drug efflux: first-order in intracellular concentration $C_{\\text{in}}$ with rate constant $k_{\\text{out}}$.\n- Intracellular metabolic transformation: first-order in intracellular concentration $C_{\\text{in}}$ with rate constant $k_{\\text{met}}$.\n- Resistant mutant: efflux rate constant is increased by a multiplicative factor $r$ relative to a baseline strain.\n- Baseline efflux rate constant: $k_{\\text{out},0}$.\n- Resistant strain efflux rate constant: $k_{\\text{out}} = r\\,k_{\\text{out},0}$.\n- Definition of Minimum Inhibitory Concentration (MIC): the extracellular concentration $[D]$ for which $C_{\\text{in}} = C^{\\star}$.\n- Parameter values:\n  - $k_{\\text{in}} = 0.40\\ \\text{min}^{-1}$\n  - $k_{\\text{out},0} = 0.10\\ \\text{min}^{-1}$\n  - $k_{\\text{met}} = 0.02\\ \\text{min}^{-1}$\n  - $C^{\\star} = 1.50\\ \\mu\\text{M}$\n  - $r = 3.5$\n- Objective: Compute the fold-change in the MIC, defined as the ratio of the resistant-strain MIC to the baseline-strain MIC, rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded. The model described is a simplified one-compartment pharmacokinetic model with first-order kinetics, which is a standard approach for modeling drug concentration dynamics within a cell. The mechanism of azole antifungals targeting CYP51 and resistance arising from the overexpression of efflux pumps (such as ABC transporters) is a well-documented phenomenon in medical microbiology.\n\nThe problem is well-posed. It provides all necessary parameters, definitions, and a clear objective. The relationships are mathematically consistent and lead to a unique, meaningful solution.\n\nThe problem is objective. The language is precise, quantitative, and free of subjective or speculative claims.\n\nTherefore, the problem is deemed valid.\n\n### Solution Derivation\nThe rate of change of the intracellular drug concentration, $C_{\\text{in}}$, is governed by a mass-balance equation. The rate of change, $\\frac{dC_{\\text{in}}}{dt}$, is the rate of drug influx minus the rates of all elimination processes (efflux and metabolism).\n\nBased on the problem statement, all processes are first-order.\n- Rate of influx = $k_{\\text{in}} [D]$\n- Rate of efflux = $k_{\\text{out}} C_{\\text{in}}$\n- Rate of metabolic transformation = $k_{\\text{met}} C_{\\text{in}}$\n\nThe differential equation describing the system is:\n$$\n\\frac{dC_{\\text{in}}}{dt} = k_{\\text{in}} [D] - k_{\\text{out}} C_{\\text{in}} - k_{\\text{met}} C_{\\text{in}}\n$$\nThis can be rearranged by factoring out $C_{\\text{in}}$ from the elimination terms:\n$$\n\\frac{dC_{\\text{in}}}{dt} = k_{\\text{in}} [D] - (k_{\\text{out}} + k_{\\text{met}}) C_{\\text{in}}\n$$\nAt steady state, the intracellular concentration is constant, meaning $\\frac{dC_{\\text{in}}}{dt} = 0$. Setting the equation to zero allows us to solve for the steady-state intracellular concentration, which we denote as $C_{\\text{in,ss}}$.\n$$\n0 = k_{\\text{in}} [D] - (k_{\\text{out}} + k_{\\text{met}}) C_{\\text{in,ss}}\n$$\nSolving for $C_{\\text{in,ss}}$ yields:\n$$\nC_{\\text{in,ss}} = \\frac{k_{\\text{in}} [D]}{k_{\\text{out}} + k_{\\text{met}}}\n$$\nThis is the general expression for the steady-state intracellular concentration.\n\nThe Minimum Inhibitory Concentration (MIC) is defined as the extracellular concentration $[D]$ at which the steady-state intracellular concentration equals the critical threshold for inhibition, $C^{\\star}$. So, we set $[D] = \\text{MIC}$ and $C_{\\text{in,ss}} = C^{\\star}$:\n$$\nC^{\\star} = \\frac{k_{\\text{in}} (\\text{MIC})}{k_{\\text{out}} + k_{\\text{met}}}\n$$\nSolving for the MIC gives:\n$$\n\\text{MIC} = \\frac{C^{\\star} (k_{\\text{out}} + k_{\\text{met}})}{k_{\\text{in}}}\n$$\nNow, we apply this formula to both the baseline (wild-type) and the resistant strains.\n\nFor the baseline strain, the efflux rate constant is $k_{\\text{out},0}$. Its MIC, denoted $\\text{MIC}_{\\text{base}}$, is:\n$$\n\\text{MIC}_{\\text{base}} = \\frac{C^{\\star} (k_{\\text{out},0} + k_{\\text{met}})}{k_{\\text{in}}}\n$$\nFor the resistant strain, the efflux rate constant is $k_{\\text{out}} = r \\cdot k_{\\text{out},0}$. Its MIC, denoted $\\text{MIC}_{\\text{res}}$, is:\n$$\n\\text{MIC}_{\\text{res}} = \\frac{C^{\\star} (r \\cdot k_{\\text{out},0} + k_{\\text{met}})}{k_{\\text{in}}}\n$$\nThe problem asks for the fold-change in the MIC, which is the ratio $\\frac{\\text{MIC}_{\\text{res}}}{\\text{MIC}_{\\text{base}}}$.\n$$\n\\text{Fold-change} = \\frac{\\text{MIC}_{\\text{res}}}{\\text{MIC}_{\\text{base}}} = \\frac{\\frac{C^{\\star} (r \\cdot k_{\\text{out},0} + k_{\\text{met}})}{k_{\\text{in}}}}{\\frac{C^{\\star} (k_{\\text{out},0} + k_{\\text{met}})}{k_{\\text{in}}}}\n$$\nThe terms $C^{\\star}$ and $k_{\\text{in}}$ cancel from the numerator and denominator, simplifying the expression to:\n$$\n\\text{Fold-change} = \\frac{r \\cdot k_{\\text{out},0} + k_{\\text{met}}}{k_{\\text{out},0} + k_{\\text{met}}}\n$$\nWe now substitute the given numerical values: $r = 3.5$, $k_{\\text{out},0} = 0.10\\ \\text{min}^{-1}$, and $k_{\\text{met}} = 0.02\\ \\text{min}^{-1}$.\n$$\n\\text{Fold-change} = \\frac{(3.5)(0.10) + 0.02}{0.10 + 0.02}\n$$\n$$\n\\text{Fold-change} = \\frac{0.35 + 0.02}{0.12} = \\frac{0.37}{0.12}\n$$\nPerforming the division:\n$$\n\\text{Fold-change} = 3.08333...\n$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\n\\text{Fold-change} \\approx 3.083\n$$\nThe fold-change represents how many times higher the MIC is for the resistant strain compared to the baseline strain due to the specified increase in efflux pump activity.",
            "answer": "$$\\boxed{3.083}$$"
        }
    ]
}